Healthcare -
Biotechnology - NASDAQ - US
$ 0.844
-7.04 %
$ 43.7 M
Market Cap
-1.28
P/E
XLO - NET INCOME
Net Income XLO - Xilio Therapeutics, Inc.
-58.2 M
LAST VALUE
18.75%
2 YEAR CAGR
-27.46%
5 YEAR CAGR
0.00%
10 YEAR CAGR